帕洛马控股
✦ 量化合理价值 计算方式说明
- 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为43.79-400.37。
- 当前价格比按平均倍数计算的合理价值(222.08)低37.1%。
估值 各估值倍数与自身5年区间的对比
同业对比 Insurance - Property & Casualty
| 公司 | 市值 | 市盈率(TTM)i | 市净率i | 股息率i |
|---|---|---|---|---|
| 帕洛马控股 (PLMR) | 3.67B | 18.76 | 3.75 | 0.00% |
| Chubb Ltd (CB) | 138.81B | 12.75 | 1.84 | 1.09% |
| Progressive (PGR) | 126.81B | 11.01 | 3.68 | 6.36% |
| The Travelers Companies (TRV) | 81.25B | 10.47 | 2.45 | 1.17% |
| Allstate (ALL) | 62.68B | 4.96 | 1.98 | 1.68% |
| WR Berkley (WRB) | 28.00B | 15.52 | 2.85 | 0.49% |
StockVane 追踪范围内同行业的其他公司。
Morningstar
当前股价高于晨星合理价值估算3.3%。
合理价值
Palomar Holdings Inc receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 5% discount to our quantitative fair value estimate of $134.97 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's profitability strengthens our estimated valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 7.0%, which sits in the top 40% globally. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are undervalued.
On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 29.6%, a core component of valuation, ranks in the bottom 30% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.
经济护城河
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
作者:Quantitative Equity Report
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
帕洛马控股 讨论区 0 条评论